Pathway Total Expected Expected Hits P.Value FDR
Influenza A 167 23 46 46 1.78E-06 0.000565
Epstein-Barr virus infection 201 27.7 50 50 1.51E-05 0.00229
Legionellosis 55 7.58 20 20 2.16E-05 0.00229
Kaposi’s sarcoma-associated herpesvirus infection 186 25.7 46 46 3.85E-05 0.00279
Hepatitis C 155 21.4 40 40 4.38E-05 0.00279
Small cell lung cancer 93 12.8 27 27 9.07E-05 0.00481
Bladder cancer 41 5.65 15 15 0.000212 0.00877
Platinum drug resistance 73 10.1 22 22 0.000221 0.00877
Complement and coagulation cascades 79 10.9 23 23 0.000282 0.00996
TNF signaling pathway 110 15.2 29 29 0.000324 0.0103
Measles 138 19 34 34 0.000413 0.011
Chronic myeloid leukemia 76 10.5 22 22 0.000415 0.011
Chemokine signaling pathway 190 26.2 43 43 0.000556 0.0136
Pathways in cancer 530 73.1 99 99 0.000689 0.0156
Glioma 75 10.3 21 21 0.000902 0.0191
Apoptosis - multiple species 33 4.55 12 12 0.000964 0.0192
Non-small cell lung cancer 66 9.1 19 19 0.00108 0.0203
Apoptosis 136 18.8 32 32 0.00139 0.0245
Rheumatoid arthritis 91 12.5 23 23 0.00237 0.0397
Type II diabetes mellitus 46 6.34 14 14 0.0027 0.041
Focal adhesion 199 27.4 42 42 0.00271 0.041
Melanoma 72 9.93 19 19 0.00328 0.0474
EGFR tyrosine kinase inhibitor resistance 79 10.9 20 20 0.00435 0.0601
ErbBsignaling pathway 85 11.7 21 21 0.0048 0.0636
Glyoxylate and dicarboxylate metabolism 30 4.14 10 10 0.00523 0.0659
Colorectal cancer 86 11.9 21 21 0.00555 0.0659
Prion diseases 35 4.83 11 11 0.00574 0.0659
Central carbon metabolism in cancer 65 8.96 17 17 0.0058 0.0659
p53 signaling pathway 72 9.93 18 18 0.00762 0.0835
Hepatitis B 163 22.5 34 34 0.00789 0.0837
Mismatch repair 23 3.17 8 8 0.00918 0.0941
Insulin signaling pathway 137 18.9 29 29 0.011 0.109
Viral myocarditis 59 8.14 15 15 0.0121 0.117
Prolactin signaling pathway 70 9.65 17 17 0.0126 0.117
IL-17 signaling pathway 93 12.8 21 21 0.0139 0.124
Carbon metabolism 116 16 25 25 0.014 0.124
Osteoclast differentiation 128 17.7 27 27 0.0145 0.124
Endocytosis 244 33.6 46 46 0.0153 0.128
Proteasome 45 6.21 12 12 0.0162 0.132
Glutathione metabolism 56 7.72 14 14 0.0174 0.136
NOD-like receptor signaling pathway 178 24.5 35 35 0.0175 0.136
Glycolysis / Gluconeogenesis 68 9.38 16 16 0.0204 0.154
D-Glutamine and D-glutamate metabolism 5 0.69 3 3 0.0211 0.156
Renal cell carcinoma 69 9.52 16 16 0.0232 0.168
Endocrine resistance 98 13.5 21 21 0.0244 0.172
PI3K-Akt signaling pathway 354 48.8 62 62 0.0253 0.175
Pertussis 76 10.5 17 17 0.0275 0.186
B cell receptor signaling pathway 71 9.79 16 16 0.0299 0.198
Platelet activation 124 17.1 25 25 0.0305 0.198
Vasopressin-regulated water reabsorption 44 6.07 11 11 0.033 0.21
Amoebiasis 96 13.2 20 20 0.0363 0.226
Viral carcinogenesis 201 27.7 37 37 0.0381 0.226
Regulation of actin cytoskeleton 214 29.5 39 39 0.039 0.226
Fc gamma R-mediated phagocytosis 91 12.5 19 19 0.0398 0.226
Hematopoietic cell lineage 97 13.4 20 20 0.04 0.226
Ferroptosis 40 5.52 10 10 0.0411 0.226
Fc epsilon RI signaling pathway 68 9.38 15 15 0.0413 0.226
Staphylococcus aureus infection 68 9.38 15 15 0.0413 0.226
Autophagy - animal 128 17.7 25 25 0.043 0.232
Toll-like receptor signaling pathway 104 14.3 21 21 0.044 0.233
Pancreatic cancer 75 10.3 16 16 0.0472 0.242
Tuberculosis 179 24.7 33 33 0.0472 0.242